Using Non-Infectious MVM and RVLP Surrogates to Predict Viral ClearanceInsourcing Purification Workflows Improves Efficiency, Recovery, and Quality

News
Article

Sponsored Content

Non-infectious mock virus particles that mimic the physicochemical properties of live infectious viruses can be used as spiking agents during viral clearance testing.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content
© 2025 MJH Life Sciences

All rights reserved.